Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals

Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals

Abstract Background The global pandemic of coronavirus disease 2019 (COVID-19) is caused by infection with the SARS-CoV-2 virus. Currently, there are three approved vaccines against SARS-CoV-2 in the USA, including two based on messenger RNA (mRNA) technology that has demonstrated high vaccine effic...

Full description

Bibliographic Details
Main Authors: Elizabeth Fraley, Cas LeMaster, Eric Geanes, Dithi Banerjee, Santosh Khanal, Elin Grundberg, Rangaraj Selvarangan, Todd Bradley
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Medicine
Subjects:
SARS-CoV-2
Antibody response
mRNA vaccine
Online Access:https://doi.org/10.1186/s12916-021-02055-9

Internet

https://doi.org/10.1186/s12916-021-02055-9

Similar Items